Despite this, considering the tight connection between defective CFTR and oxidative stress, it should be noted that the combined approach of antioxidant molecules with various formulations of correctors and potentiators has shown positive therapeutic effects in CF patients and could represent an approach to be further explored in the near future. This evidence concerns the gene CFTR and cystic fibrosis.